Palantir Technologies Inc.
For the period ended Dec 31, 2025. Filed Feb 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 17, 2026
PLTR$167.99-2.1%Stored close · as of Nov 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Checking your notes…
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating activities | |||
| Net income | $1,634,644 | $467,918 | $217,375 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 26,145 | 31,587 | 33,354 |
| Stock-based compensation | 684,033 | 691,638 | 475,903 |
| Unrealized and realized (gain) loss from marketable securities, net | 21,228 | 19,306 | 13,160 |
| Noncash consideration | (37,244) | (52,521) | (46,609) |
| Other operating activities | 15,630 | 66,034 | 12,764 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable, net | (450,429) | (211,157) | (106,159) |
| Prepaid expenses and other assets | 51,979 | 11,883 | (2,955) |
| Accounts payable and accrued liabilities | 4,659 | 96,793 | 21,063 |
| Contract liabilities | 238,688 | 76,796 | 143,859 |
| Other liabilities | (54,860) | (44,412) | (49,572) |
| Net cash provided by operating activities | 2,134,473 | 1,153,865 | 712,183 |
| Investing activities | |||
| Purchases of property and equipment | (33,882) | (12,634) | (15,114) |
| Purchases of marketable securities | (7,702,060) | (5,395,913) | (5,636,406) |
| Proceeds from sales and redemption of marketable securities | 5,026,315 | 5,073,507 | 2,889,268 |
| Purchases of privately-held securities | (72,924) | (5,615) | — |
| Other investing activities | (1,000) | — | 51,072 |
| Net cash used in investing activities | (2,783,551) | (340,655) | (2,711,180) |
| Financing activities | |||
| Proceeds from the exercise of common stock options | 129,107 | 745,396 | 218,238 |
| Repurchases of common stock | (74,985) | (64,196) | — |
| Taxes paid related to net share settlement of equity awards | (81,117) | (218,280) | — |
| Other financing activities | 85 | 444 | 601 |
| Net cash provided by (used in) financing activities | (26,910) | 463,364 | 218,839 |
| Effect of foreign exchange on cash, cash equivalents, and restricted cash | 7,477 | (6,745) | 2,930 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | (668,511) | 1,269,829 | (1,777,228) |
| Cash, cash equivalents, and restricted cash - beginning of period | 2,119,936 | 850,107 | 2,627,335 |
| Cash, cash equivalents, and restricted cash - end of period | $1,451,425 | $2,119,936 | $850,107 |
| Supplemental disclosures of cash flow information | |||
| Noncash investing and financing activities | |||
| Accrued taxes related to net share settlement of equity awards | $— | $84,207 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.